U.S. FDA Approves DECNUPAZ™ (pivekimab sunirine-pvzy) for Treatment of Adult Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare and Aggressive Blood Cancer With Limited Treatment Options
8 September 2026
No Comments
NORTH CHICAGO, Ill., May 27, 2026 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the U.S. Food